- Home
- PRTA vs ASIX Comparison
PRTA vs ASIX Comparison
Compare PRTA & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | ASIX |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 466.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTA | ASIX |
|---|---|---|
| Price | $9.05 | $16.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $18.86 | ★ $25.50 |
| AVG Volume (30 Days) | ★ 511.6K | 341.1K |
| Earning Date | 02-19-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 3.91% |
| EPS Growth | N/A | ★ 35.47 |
| EPS | N/A | ★ 1.92 |
| Revenue | $11,786,000.00 | ★ $1,491,348,000.00 |
| Revenue This Year | N/A | $1.02 |
| Revenue Next Year | $1,183.79 | $2.80 |
| P/E Ratio | ★ N/A | $8.53 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $14.10 |
| 52 Week High | $16.67 | $32.44 |
Technical Indicators
Market Signals| Indicator | PRTA | ASIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 40.67 |
| Support Level | $8.65 | $16.10 |
| Resistance Level | $10.53 | $17.38 |
| Average True Range (ATR) | 0.48 | 0.61 |
| MACD | 0.02 | -0.20 |
| Stochastic Oscillator | 21.81 | 8.65 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.